A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia.
about
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A phase 2 trial of high dose l ...... mia with trilineage dysplasia.
@en
A phase 2 trial of high dose l ...... mia with trilineage dysplasia.
@nl
type
label
A phase 2 trial of high dose l ...... mia with trilineage dysplasia.
@en
A phase 2 trial of high dose l ...... mia with trilineage dysplasia.
@nl
prefLabel
A phase 2 trial of high dose l ...... mia with trilineage dysplasia.
@en
A phase 2 trial of high dose l ...... mia with trilineage dysplasia.
@nl
P2093
P2860
P356
P1476
A phase 2 trial of high dose l ...... mia with trilineage dysplasia.
@en
P2093
Amer M Zeidan
Amy DeZern
B Douglas Smith
Hetty E Carraway
Ivana Gojo
Steven D Gore
P2860
P304
P356
10.1111/BJH.14407
P407
P577
2016-10-28T00:00:00Z